Frichem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.10 M
- Company Age 28 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 9.99 Cr
- Revenue Growth -14.67%
- Profit Growth 50.46%
- Ebitda 26.10%
- Net Worth -0.15%
- Total Assets 4.78%
About Frichem
Frichem Private Limited (FPL) is a Private Limited Indian Non-Government Company incorporated in India on 05 June 1996 and has a history of 28 years and seven months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹9.99 Cr.
Nandini Sandip and Sharang Parekh serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U99999MH1996PTC100017
-
Company No.
100017
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
05 Jun 1996
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Frichem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sharang Parekh
|
Director | 01-Apr-2015 | Current |
|
Nandini Sandip
|
Director | 30-Nov-2020 | Current |
Financial Performance of Frichem.
Frichem Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 14.67% decrease. The company also saw a substantial improvement in profitability, with a 50.46% increase in profit. The company's net worth dipped by a decrease of 0.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Frichem?
In 2021, Frichem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Synergia Sciences Private LimitedNandini Sandip and Sharang Parekh are mutual person
-
Aaress Life Sciences Private LimitedNandini Sandip and Sharang Parekh are mutual person
Charges (Loans)
₹99.90 M
₹0
Charges Breakdown by Lending Institutions
- Others : 9.99 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 25 Feb 2021 | Others | ₹9.99 Cr | Open |
How Many Employees Work at Frichem?
Unlock and access historical data on people associated with Frichem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Frichem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Frichem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
